Search Within

Brian Kushner

Formats
  1. Journal Article (181)
  2. Meeting Abstract (113)
  3. Conference Paper (9)
  4. Book Section (4)
  5. Editorial (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Neuroblastoma Service (311)
  2. Pediatrics, Department of (311)
  3. GSK Faculty (233)
  4. Tow Center for Developmental Oncology (TCDO) (233)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (230)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (227)

More Groups

People
  1. Nai-Kong Cheung (227)
  2. Shakeel Modak (154)
  3. Kim Kramer (132)
  4. Michael La Quaglia (80)
  5. Ellen Basu (68)
  6. Stephen Roberts (63)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (18)
  4. 2022 (9)
  5. 2021 (13)
  6. 2020 (14)

More Years

Publications
  1. Pediatric Blood and Cancer (65)
  2. Journal of Clinical Oncology (60)
  3. International Journal of Radiation Oncology, Biology, Physics (26)
  4. Cancer (19)
  5. Medical and Pediatric Oncology (10)
  6. Neuro-Oncology (9)

More Publications

Publishers
  1. Wiley Periodicals, Inc (65)
  2. American Society of Clinical Oncology (61)
  3. Elsevier Inc. (33)
  4. Wiley Blackwell (19)
  5. American Association for Cancer Research (14)
  6. Oxford University Press (14)

More Publishers

Results (311)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Efficacy and updated safety results from pivotal phase II trial 201 of naxitamab (Hu3F8): A humanized GD2-targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)
    Meeting Abstract

    Mora, J.; Chan, G. C.; Morgenstern, D. A.; Nysom, K.; Bear, M.; Worsaae Dalby, L.; Lisby, S.; Kushner, B. H.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Pivotal trial 201 data on outpatient administration of naxitamab (Hu3F8), a humanized GD2 targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)
    Meeting Abstract

    Morgenstern, D. A.; Mora, J.; Chan, G. C.; Nysom, K.; Bear, M.; Worsaae Dalby, L.; Lisby, S.; Kushner, B. H.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • International, multicenter phase II trial with humanized anti-GD2 monoclonal antibody naxitamab for treatment of refractory/relapsed high-risk neuroblastoma: Efficacy and safety data
    Meeting Abstract

    Mora, J.; Chan, G.; Morgenstern, D.; Nysom, K.; Bear, M.; Dalby, L. W.; Lisby, S.; Kushner, B.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Reactive regional lymphadenopathy associated with neuroblastoma immunotherapy
    Meeting Abstract

    Lentini-Rivera, A.; Kushner, B.; Modak, S.; Price, A.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Surveillance for early detection of neuroblastoma central nervous system relapse
    Meeting Abstract

    Modak, S.; Kushner, B.; Cheung, N. K.; Kramer, K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Favorable toxicity profile of bivalent GD2/GD3 neuroblastoma vaccine
    Meeting Abstract

    Modak, S.; Cheung, N. K.; Basu, E.; Roberts, S.; Kushner, B.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Long-term survivors receive multimodality treatment of second central nervous system relapse in pediatric patients with neuroblastoma
    Meeting Abstract

    Tringale, K. R.; Kramer, K.; Luo, L.; Casey, D. L.; Kushner, B.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save